Quince Therapeutics, Inc. Common Stock — Institutional Ownership
Which tracked institutions hold QNCX, and how they changed the position last quarter. Latest holdings as of Jun 30, 2026. Source: SEC 13-F filings.
7
Funds holding
$191961
Total value held
Buying
7 added/new · 0 reduced
| # | Institution | Value | Shares | Δ Shares | Change (QoQ) |
|---|---|---|---|---|---|
| 1 | Ubs Group Ag | $86039 | 4730 | +4730 | NEW BUY |
| 2 | Morgan Stanley | $74288 | 4084 | +4084 | NEW BUY |
| 3 | Blackrock, Inc. | $30959 | 1702 | +1702 | NEW BUY |
| 4 | Barclays Plc | $491 | 27 | +27 | NEW BUY |
| 5 | Wells Fargo & Company/Mn | $182 | 10 | +10 | NEW BUY |
| 6 | Jpmorgan Chase & Co | $2 | 2 | +2 | NEW BUY |
| 7 | Royal Bank Of Canada | $0 | 1 | +1 | NEW BUY |
Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.